http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2021, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 21 Sep 2021 16:39:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++First+Wave+BioPharma%2C+++++For%3A+Sep+21/18965751.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++First+Wave+BioPharma%2C+++++For%3A+Sep+21/18965751.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++First+Wave+BioPharma%2C+++++For%3A+Sep+21/18965751.html Tue, 21 Sep 2021 16:39:00 -0500 AZRX http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+to+Change+Corporate+Name+to+First+Wave+BioPharma+Today/18964550.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+to+Change+Corporate+Name+to+First+Wave+BioPharma+Today/18964550.html for the full story. http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+to+Change+Corporate+Name+to+First+Wave+BioPharma+Today/18964550.html Tue, 21 Sep 2021 12:47:00 -0500 A.09642568 AZRX FWBI http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+to+Change+Corporate+Name+to+First+Wave+BioPharma+Today/18964550.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+to+Change+Corporate+Name+to+First+Wave+BioPharma+Today/18964550.html for the full story. http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+to+Change+Corporate+Name+to+First+Wave+BioPharma+Today/18964550.html Tue, 21 Sep 2021 12:47:00 -0500 A.09642568 AZRX FWBI http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+to+Change+Corporate+Name+to+First+Wave+BioPharma+Today/18964550.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+to+Change+Corporate+Name+to+First+Wave+BioPharma+Today/18964550.html for the full story. http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+to+Change+Corporate+Name+to+First+Wave+BioPharma+Today/18964550.html Tue, 21 Sep 2021 12:47:00 -0500 A.09642568 AZRX FWBI http://www.streetinsider.com/Globe+Newswire/AzurRx+BioPharma+to+Change+Corporate+Name+to+First+Wave+BioPharma+Today/18964550.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/AzurRx+BioPharma+to+Change+Corporate+Name+to+First+Wave+BioPharma+Today/18964550.html for the full story. http://www.streetinsider.com/Globe+Newswire/AzurRx+BioPharma+to+Change+Corporate+Name+to+First+Wave+BioPharma+Today/18964550.html Tue, 21 Sep 2021 12:47:00 -0500 A.09642568 AZRX FWBI http://www.streetinsider.com/Globe+Newswire/AzurRx+BioPharma+to+Change+Corporate+Name+to+First+Wave+BioPharma+Today/18964550.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/AzurRx+BioPharma+to+Change+Corporate+Name+to+First+Wave+BioPharma+Today/18964550.html for the full story. http://www.streetinsider.com/Globe+Newswire/AzurRx+BioPharma+to+Change+Corporate+Name+to+First+Wave+BioPharma+Today/18964550.html Tue, 21 Sep 2021 12:47:00 -0500 A.09642568 AZRX FWBI http://www.streetinsider.com/Globe+Newswire/AzurRx+BioPharma+to+Change+Corporate+Name+to+First+Wave+BioPharma+Today/18964550.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/AzurRx+BioPharma+to+Change+Corporate+Name+to+First+Wave+BioPharma+Today/18964550.html for the full story. http://www.streetinsider.com/Globe+Newswire/AzurRx+BioPharma+to+Change+Corporate+Name+to+First+Wave+BioPharma+Today/18964550.html Tue, 21 Sep 2021 12:47:00 -0500 A.09642568 AZRX FWBI http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AzurRx+BioPharma%2C+Inc.++++For%3A+Sep+14/18939930.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AzurRx+BioPharma%2C+Inc.++++For%3A+Sep+14/18939930.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AzurRx+BioPharma%2C+Inc.++++For%3A+Sep+14/18939930.html Tue, 14 Sep 2021 17:13:00 -0500 AZRX http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+CEO+Issues+Letter+to+Shareholders+Regarding+Recent+Acquisition+of+First+Wave+Bio+and+Creation+of+First+Wave+BioPharma/18935560.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+CEO+Issues+Letter+to+Shareholders+Regarding+Recent+Acquisition+of+First+Wave+Bio+and+Creation+of+First+Wave+BioPharma/18935560.html for the full story. http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+CEO+Issues+Letter+to+Shareholders+Regarding+Recent+Acquisition+of+First+Wave+Bio+and+Creation+of+First+Wave+BioPharma/18935560.html Tue, 14 Sep 2021 07:30:00 -0500 A.06822034 AZRX http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+CEO+Issues+Letter+to+Shareholders+Regarding+Recent+Acquisition+of+First+Wave+Bio+and+Creation+of+First+Wave+BioPharma/18935560.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+CEO+Issues+Letter+to+Shareholders+Regarding+Recent+Acquisition+of+First+Wave+Bio+and+Creation+of+First+Wave+BioPharma/18935560.html for the full story. http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+CEO+Issues+Letter+to+Shareholders+Regarding+Recent+Acquisition+of+First+Wave+Bio+and+Creation+of+First+Wave+BioPharma/18935560.html Tue, 14 Sep 2021 07:30:00 -0500 A.06822034 AZRX http://www.streetinsider.com/Globe+Newswire/AzurRx+BioPharma+CEO+Issues+Letter+to+Shareholders+Regarding+Recent+Acquisition+of+First+Wave+Bio+and+Creation+of+First+Wave+BioPharma/18935560.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/AzurRx+BioPharma+CEO+Issues+Letter+to+Shareholders+Regarding+Recent+Acquisition+of+First+Wave+Bio+and+Creation+of+First+Wave+BioPharma/18935560.html for the full story. http://www.streetinsider.com/Globe+Newswire/AzurRx+BioPharma+CEO+Issues+Letter+to+Shareholders+Regarding+Recent+Acquisition+of+First+Wave+Bio+and+Creation+of+First+Wave+BioPharma/18935560.html Tue, 14 Sep 2021 07:30:00 -0500 A.06822034 AZRX http://www.streetinsider.com/Globe+Newswire/AzurRx+BioPharma+CEO+Issues+Letter+to+Shareholders+Regarding+Recent+Acquisition+of+First+Wave+Bio+and+Creation+of+First+Wave+BioPharma/18935560.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/AzurRx+BioPharma+CEO+Issues+Letter+to+Shareholders+Regarding+Recent+Acquisition+of+First+Wave+Bio+and+Creation+of+First+Wave+BioPharma/18935560.html for the full story. http://www.streetinsider.com/Globe+Newswire/AzurRx+BioPharma+CEO+Issues+Letter+to+Shareholders+Regarding+Recent+Acquisition+of+First+Wave+Bio+and+Creation+of+First+Wave+BioPharma/18935560.html Tue, 14 Sep 2021 07:30:00 -0500 A.06822034 AZRX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AzurRx+BioPharma%2C+Inc.++++For%3A+Sep+09++Filed+by%3A+Coelho+Mary+Theresa/18934280.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AzurRx+BioPharma%2C+Inc.++++For%3A+Sep+09++Filed+by%3A+Coelho+Mary+Theresa/18934280.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AzurRx+BioPharma%2C+Inc.++++For%3A+Sep+09++Filed+by%3A+Coelho+Mary+Theresa/18934280.html Mon, 13 Sep 2021 20:08:00 -0500 AZRX http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AzurRx+BioPharma%2C+Inc.++++For%3A+Sep+13/18929956.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AzurRx+BioPharma%2C+Inc.++++For%3A+Sep+13/18929956.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AzurRx+BioPharma%2C+Inc.++++For%3A+Sep+13/18929956.html Mon, 13 Sep 2021 06:18:00 -0500 AZRX http://www.streetinsider.com/Corporate+News/AzurRx+BioPharma+%28AZRX%29+Announces+Acquisition+of+First+Wave+Bio/18929933.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/AzurRx+BioPharma+%28AZRX%29+Announces+Acquisition+of+First+Wave+Bio/18929933.html for the full story. http://www.streetinsider.com/Corporate+News/AzurRx+BioPharma+%28AZRX%29+Announces+Acquisition+of+First+Wave+Bio/18929933.html Mon, 13 Sep 2021 06:12:45 -0500 AZRX http://www.streetinsider.com/Management+Comments/AzurRx+BioPharma+%28AZRX%29+Announces+Acquisition+of+First+Wave+Bio/18929933.html Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/AzurRx+BioPharma+%28AZRX%29+Announces+Acquisition+of+First+Wave+Bio/18929933.html for the full story. http://www.streetinsider.com/Management+Comments/AzurRx+BioPharma+%28AZRX%29+Announces+Acquisition+of+First+Wave+Bio/18929933.html Mon, 13 Sep 2021 06:12:45 -0500 AZRX http://www.streetinsider.com/Mergers+and+Acquisitions/AzurRx+BioPharma+%28AZRX%29+Announces+Acquisition+of+First+Wave+Bio/18929933.html Visit StreetInsider.com at http://www.streetinsider.com/Mergers+and+Acquisitions/AzurRx+BioPharma+%28AZRX%29+Announces+Acquisition+of+First+Wave+Bio/18929933.html for the full story. http://www.streetinsider.com/Mergers+and+Acquisitions/AzurRx+BioPharma+%28AZRX%29+Announces+Acquisition+of+First+Wave+Bio/18929933.html Mon, 13 Sep 2021 06:12:45 -0500 AZRX http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html for the full story. http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html Mon, 13 Sep 2021 06:00:00 -0500 A.02927364 A.06822034 A.09642568 A.17568957 A.17568957 AZRX http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html for the full story. http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html Mon, 13 Sep 2021 06:00:00 -0500 A.02927364 A.06822034 A.09642568 A.17568957 A.17568957 AZRX http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html for the full story. http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html Mon, 13 Sep 2021 06:00:00 -0500 A.02927364 A.06822034 A.09642568 A.17568957 A.17568957 AZRX http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html for the full story. http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html Mon, 13 Sep 2021 06:00:00 -0500 A.02927364 A.06822034 A.09642568 A.17568957 A.17568957 AZRX http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html for the full story. http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html Mon, 13 Sep 2021 06:00:00 -0500 A.02927364 A.06822034 A.09642568 A.17568957 A.17568957 AZRX http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html for the full story. http://www.streetinsider.com/Press+Releases/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html Mon, 13 Sep 2021 06:00:00 -0500 A.02927364 A.06822034 A.09642568 A.17568957 A.17568957 AZRX http://www.streetinsider.com/Globe+Newswire/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html for the full story. http://www.streetinsider.com/Globe+Newswire/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html Mon, 13 Sep 2021 06:00:00 -0500 A.02927364 A.06822034 A.09642568 A.17568957 A.17568957 AZRX http://www.streetinsider.com/Globe+Newswire/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html for the full story. http://www.streetinsider.com/Globe+Newswire/AzurRx+BioPharma+Announces+Acquisition+of+First+Wave+Bio+and+its+Proprietary+Niclosamide+Formulations+Targeting+Multi-Billion+Dollar+Inflammatory+Bowel+Disease+Indications/18929682.html Mon, 13 Sep 2021 06:00:00 -0500 A.02927364 A.06822034 A.09642568 A.17568957 A.17568957 AZRX